Stefan Riedel, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anti-Bacterial Agents | 15 | 2021 | 7399 | 1.630 |
Why?
|
| Bacteremia | 7 | 2017 | 978 | 1.400 |
Why?
|
| Neisseria gonorrhoeae | 5 | 2019 | 239 | 1.330 |
Why?
|
| Blood | 5 | 2011 | 584 | 1.210 |
Why?
|
| Calcitonin | 4 | 2013 | 329 | 1.180 |
Why?
|
| Culture Media | 4 | 2011 | 899 | 1.100 |
Why?
|
| Microbial Sensitivity Tests | 12 | 2021 | 1943 | 1.040 |
Why?
|
| Fungi | 3 | 2023 | 338 | 1.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 5 | 2021 | 586 | 0.970 |
Why?
|
| Protein Precursors | 4 | 2013 | 1133 | 0.960 |
Why?
|
| Drug Resistance, Bacterial | 5 | 2019 | 1054 | 0.960 |
Why?
|
| Bacteriological Techniques | 5 | 2019 | 279 | 0.920 |
Why?
|
| Mycobacterium | 2 | 2023 | 251 | 0.830 |
Why?
|
| Water Microbiology | 3 | 2019 | 113 | 0.780 |
Why?
|
| Microbiological Techniques | 2 | 2014 | 98 | 0.770 |
Why?
|
| Blood Specimen Collection | 2 | 2016 | 238 | 0.760 |
Why?
|
| Reagins | 1 | 2020 | 7 | 0.730 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2020 | 37 | 0.710 |
Why?
|
| Enterococcus | 2 | 2014 | 160 | 0.710 |
Why?
|
| Treponema pallidum | 1 | 2020 | 47 | 0.700 |
Why?
|
| Spectinomycin | 1 | 2019 | 9 | 0.670 |
Why?
|
| Nebramycin | 1 | 2019 | 10 | 0.660 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2021 | 610 | 0.660 |
Why?
|
| Laboratories | 3 | 2021 | 460 | 0.650 |
Why?
|
| Gram-Negative Bacteria | 3 | 2017 | 272 | 0.640 |
Why?
|
| Bacteria | 4 | 2021 | 2196 | 0.630 |
Why?
|
| Disk Diffusion Antimicrobial Tests | 1 | 2017 | 8 | 0.600 |
Why?
|
| Enterobacteriaceae | 1 | 2019 | 172 | 0.590 |
Why?
|
| Penicillanic Acid | 1 | 2017 | 42 | 0.580 |
Why?
|
| Coccidioidomycosis | 1 | 2017 | 37 | 0.580 |
Why?
|
| Syphilis | 1 | 2020 | 243 | 0.580 |
Why?
|
| Cephalosporins | 2 | 2017 | 204 | 0.570 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2017 | 236 | 0.560 |
Why?
|
| Lung Diseases, Fungal | 1 | 2017 | 126 | 0.550 |
Why?
|
| Sepsis | 3 | 2016 | 2579 | 0.500 |
Why?
|
| Macrolides | 2 | 2017 | 205 | 0.500 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 486 | 0.500 |
Why?
|
| Cryptococcosis | 2 | 2015 | 104 | 0.490 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 806 | 0.470 |
Why?
|
| Virus Diseases | 1 | 2019 | 719 | 0.430 |
Why?
|
| Staphylococcus aureus | 2 | 2014 | 1458 | 0.430 |
Why?
|
| Knee Joint | 2 | 2020 | 1664 | 0.430 |
Why?
|
| Diagnosis | 1 | 2014 | 156 | 0.420 |
Why?
|
| Bacterial Infections | 2 | 2019 | 1402 | 0.410 |
Why?
|
| Mycobacterium marinum | 2 | 2017 | 29 | 0.410 |
Why?
|
| Silver Nitrate | 1 | 2011 | 13 | 0.400 |
Why?
|
| Cryptococcus | 1 | 2011 | 28 | 0.400 |
Why?
|
| Diagnostic Tests, Routine | 5 | 2021 | 785 | 0.390 |
Why?
|
| Autopsy | 2 | 2021 | 1003 | 0.380 |
Why?
|
| Gonorrhea | 4 | 2019 | 346 | 0.360 |
Why?
|
| Triazoles | 2 | 2015 | 902 | 0.360 |
Why?
|
| Candidemia | 1 | 2011 | 38 | 0.360 |
Why?
|
| Trichomonas Infections | 1 | 2010 | 41 | 0.350 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2020 | 1369 | 0.350 |
Why?
|
| Trichomonas vaginalis | 1 | 2010 | 70 | 0.350 |
Why?
|
| Candida | 1 | 2011 | 173 | 0.340 |
Why?
|
| Calcitonin Gene-Related Peptide | 4 | 2013 | 314 | 0.340 |
Why?
|
| Melanins | 1 | 2011 | 289 | 0.340 |
Why?
|
| Clinical Laboratory Techniques | 5 | 2022 | 747 | 0.330 |
Why?
|
| Ciprofloxacin | 3 | 2020 | 312 | 0.330 |
Why?
|
| Anti-Infective Agents | 1 | 2016 | 981 | 0.320 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 259 | 0.310 |
Why?
|
| Antifungal Agents | 3 | 2020 | 749 | 0.310 |
Why?
|
| Vancomycin Resistance | 1 | 2008 | 126 | 0.300 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 198 | 0.300 |
Why?
|
| Sensitivity and Specificity | 11 | 2022 | 14637 | 0.290 |
Why?
|
| Burn Units | 2 | 2018 | 141 | 0.290 |
Why?
|
| Genotype | 1 | 2021 | 12951 | 0.270 |
Why?
|
| Hospitals, Veterans | 1 | 2008 | 395 | 0.260 |
Why?
|
| Staphylococcal Infections | 3 | 2010 | 1406 | 0.260 |
Why?
|
| Polymerase Chain Reaction | 4 | 2023 | 6070 | 0.260 |
Why?
|
| Cross Infection | 2 | 2012 | 1430 | 0.250 |
Why?
|
| Communicable Diseases | 1 | 2014 | 876 | 0.250 |
Why?
|
| Drug Contamination | 1 | 2006 | 152 | 0.240 |
Why?
|
| 1-Naphthylamine | 1 | 2004 | 49 | 0.240 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2010 | 591 | 0.240 |
Why?
|
| Carrier State | 1 | 2008 | 525 | 0.240 |
Why?
|
| Sarcina | 1 | 2023 | 10 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7366 | 0.230 |
Why?
|
| Quality Control | 2 | 2017 | 825 | 0.220 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 694 | 0.220 |
Why?
|
| Humans | 60 | 2024 | 757566 | 0.220 |
Why?
|
| Platelet Transfusion | 1 | 2006 | 294 | 0.220 |
Why?
|
| Freezing | 1 | 2024 | 305 | 0.220 |
Why?
|
| Nucleic Acid Amplification Techniques | 3 | 2021 | 328 | 0.210 |
Why?
|
| Fetal Blood | 1 | 2009 | 1342 | 0.200 |
Why?
|
| Intensive Care Units | 3 | 2018 | 3732 | 0.200 |
Why?
|
| Menisci, Tibial | 1 | 2004 | 269 | 0.200 |
Why?
|
| Nasopharynx | 2 | 2022 | 394 | 0.200 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2021 | 17 | 0.190 |
Why?
|
| Streptococcus pneumoniae | 1 | 2007 | 731 | 0.190 |
Why?
|
| Proteus mirabilis | 1 | 2021 | 25 | 0.190 |
Why?
|
| Mycoses | 2 | 2017 | 386 | 0.190 |
Why?
|
| Mucorales | 1 | 2021 | 35 | 0.190 |
Why?
|
| Arthrodermataceae | 1 | 2020 | 7 | 0.190 |
Why?
|
| Unnecessary Procedures | 2 | 2015 | 411 | 0.190 |
Why?
|
| Maryland | 2 | 2019 | 275 | 0.190 |
Why?
|
| Oils, Volatile | 1 | 2020 | 14 | 0.190 |
Why?
|
| Ceftazidime | 1 | 2020 | 57 | 0.180 |
Why?
|
| Tetracycline | 2 | 2018 | 219 | 0.180 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2021 | 47 | 0.180 |
Why?
|
| Neutralization Tests | 1 | 2022 | 728 | 0.180 |
Why?
|
| Specimen Handling | 2 | 2024 | 702 | 0.180 |
Why?
|
| Fever | 1 | 2008 | 1617 | 0.180 |
Why?
|
| Automation, Laboratory | 1 | 2020 | 103 | 0.170 |
Why?
|
| Enterococcus faecalis | 1 | 2021 | 246 | 0.170 |
Why?
|
| Atlantic Ocean | 1 | 2019 | 24 | 0.170 |
Why?
|
| West Virginia | 1 | 2019 | 31 | 0.170 |
Why?
|
| Injections, Intra-Articular | 1 | 2020 | 279 | 0.170 |
Why?
|
| Stomach | 1 | 2023 | 694 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2021 | 252 | 0.160 |
Why?
|
| Rivers | 1 | 2019 | 64 | 0.160 |
Why?
|
| Germ Cells | 1 | 2022 | 634 | 0.160 |
Why?
|
| Dermatomycoses | 1 | 2018 | 48 | 0.150 |
Why?
|
| Disease Outbreaks | 2 | 2018 | 1756 | 0.150 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 1530 | 0.150 |
Why?
|
| Hyphae | 1 | 2017 | 52 | 0.140 |
Why?
|
| Penicillium | 1 | 2017 | 22 | 0.140 |
Why?
|
| Spores, Fungal | 1 | 2017 | 90 | 0.140 |
Why?
|
| Gloves, Surgical | 1 | 2017 | 24 | 0.140 |
Why?
|
| Saliva | 1 | 2021 | 820 | 0.140 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 364 | 0.140 |
Why?
|
| Limit of Detection | 3 | 2022 | 270 | 0.140 |
Why?
|
| Cyclonic Storms | 1 | 2018 | 116 | 0.130 |
Why?
|
| Blood Platelets | 1 | 2006 | 2476 | 0.130 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 4540 | 0.130 |
Why?
|
| beta-Lactamases | 1 | 2017 | 304 | 0.120 |
Why?
|
| Genes, Bacterial | 1 | 2019 | 1070 | 0.120 |
Why?
|
| Antigens, Fungal | 1 | 2015 | 69 | 0.120 |
Why?
|
| Clostridium septicum | 1 | 2014 | 2 | 0.120 |
Why?
|
| Gas Gangrene | 1 | 2014 | 9 | 0.120 |
Why?
|
| Hemolysis | 1 | 2016 | 423 | 0.120 |
Why?
|
| Catheter-Related Infections | 1 | 2017 | 273 | 0.120 |
Why?
|
| Sentinel Surveillance | 1 | 2016 | 292 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2020 | 1468 | 0.120 |
Why?
|
| Phlebotomy | 1 | 2015 | 137 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2020 | 1469 | 0.110 |
Why?
|
| Refrigeration | 1 | 2013 | 27 | 0.110 |
Why?
|
| Chromatography, Affinity | 1 | 2015 | 532 | 0.110 |
Why?
|
| Daptomycin | 1 | 2014 | 71 | 0.110 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2013 | 34 | 0.110 |
Why?
|
| Oxazolidinones | 1 | 2014 | 97 | 0.110 |
Why?
|
| Serum Amyloid P-Component | 1 | 2013 | 46 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 15207 | 0.110 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 1275 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 327 | 0.110 |
Why?
|
| Lung | 3 | 2024 | 9973 | 0.110 |
Why?
|
| Thyroglobulin | 1 | 2013 | 111 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 1931 | 0.100 |
Why?
|
| Equipment Contamination | 1 | 2014 | 179 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2017 | 527 | 0.100 |
Why?
|
| Acute-Phase Proteins | 1 | 2013 | 250 | 0.100 |
Why?
|
| Acetamides | 1 | 2014 | 255 | 0.100 |
Why?
|
| Silver Staining | 1 | 2011 | 62 | 0.100 |
Why?
|
| Vasopressins | 1 | 2013 | 351 | 0.100 |
Why?
|
| Ascomycota | 1 | 2012 | 81 | 0.100 |
Why?
|
| Vagina | 1 | 2017 | 828 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2017 | 2020 | 0.090 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2012 | 173 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 1384 | 0.090 |
Why?
|
| Vancomycin | 1 | 2014 | 503 | 0.090 |
Why?
|
| Orthopedic Procedures | 1 | 2020 | 1261 | 0.090 |
Why?
|
| Agar | 1 | 2010 | 55 | 0.090 |
Why?
|
| Blood Coagulation | 1 | 2016 | 1150 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2013 | 696 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2021 | 1516 | 0.090 |
Why?
|
| Antiprotozoal Agents | 1 | 2010 | 94 | 0.090 |
Why?
|
| Burns | 2 | 2018 | 1849 | 0.080 |
Why?
|
| Middle Aged | 14 | 2024 | 219192 | 0.080 |
Why?
|
| Metronidazole | 1 | 2010 | 231 | 0.080 |
Why?
|
| Male | 16 | 2024 | 358180 | 0.080 |
Why?
|
| Urine | 1 | 2010 | 362 | 0.080 |
Why?
|
| Outpatients | 1 | 2017 | 1590 | 0.080 |
Why?
|
| Registries | 1 | 2024 | 8164 | 0.080 |
Why?
|
| Viral Load | 3 | 2022 | 3321 | 0.080 |
Why?
|
| Myocardium | 1 | 2021 | 4690 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2017 | 1666 | 0.080 |
Why?
|
| Aged | 10 | 2024 | 167890 | 0.070 |
Why?
|
| Operating Rooms | 1 | 2014 | 789 | 0.070 |
Why?
|
| Gram-Positive Bacteria | 1 | 2008 | 178 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2023 | 79984 | 0.070 |
Why?
|
| Temperature | 1 | 2013 | 2217 | 0.070 |
Why?
|
| Infection Control | 1 | 2014 | 982 | 0.070 |
Why?
|
| Nasal Cavity | 1 | 2008 | 304 | 0.070 |
Why?
|
| Female | 18 | 2024 | 389943 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 2167 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2023 | 58558 | 0.070 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2008 | 343 | 0.060 |
Why?
|
| Kidney | 1 | 2021 | 7012 | 0.060 |
Why?
|
| Patient Admission | 2 | 2014 | 1364 | 0.060 |
Why?
|
| Pneumonia | 1 | 2017 | 2127 | 0.060 |
Why?
|
| Liver | 1 | 2021 | 7502 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 2914 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2009 | 664 | 0.060 |
Why?
|
| Virus Cultivation | 1 | 2024 | 88 | 0.060 |
Why?
|
| Lung Compliance | 1 | 2024 | 201 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2017 | 5951 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2742 | 0.060 |
Why?
|
| Rectum | 1 | 2008 | 891 | 0.060 |
Why?
|
| Clostridium | 1 | 2023 | 100 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3206 | 0.050 |
Why?
|
| Drug Evaluation | 1 | 2004 | 642 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2010 | 1348 | 0.050 |
Why?
|
| RNA, Viral | 2 | 2021 | 2837 | 0.050 |
Why?
|
| Microbial Viability | 1 | 2024 | 238 | 0.050 |
Why?
|
| Adult | 10 | 2024 | 219725 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2009 | 1007 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3705 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 1991 | 0.050 |
Why?
|
| Sheep | 1 | 2004 | 1439 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3809 | 0.050 |
Why?
|
| Influenza B virus | 1 | 2021 | 52 | 0.050 |
Why?
|
| Immunologic Tests | 1 | 2022 | 103 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2330 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 1 | 2014 | 2181 | 0.050 |
Why?
|
| Fluoroquinolones | 2 | 2017 | 308 | 0.050 |
Why?
|
| Microsporum | 1 | 2020 | 7 | 0.050 |
Why?
|
| Trichophyton | 1 | 2020 | 20 | 0.050 |
Why?
|
| Antibodies | 1 | 2009 | 2420 | 0.050 |
Why?
|
| Time Factors | 4 | 2015 | 39811 | 0.050 |
Why?
|
| Europe | 1 | 2007 | 3413 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2024 | 699 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2022 | 384 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4937 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 2004 | 619 | 0.040 |
Why?
|
| Adolescent | 4 | 2014 | 87819 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 241 | 0.040 |
Why?
|
| Knee Injuries | 1 | 2004 | 489 | 0.040 |
Why?
|
| Time | 1 | 2021 | 543 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 13952 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2013 | 2326 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2010 | 26176 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 296 | 0.040 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2021 | 149 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2024 | 717 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2021 | 361 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 12870 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 651 | 0.040 |
Why?
|
| Models, Animal | 1 | 2004 | 2110 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2021 | 457 | 0.040 |
Why?
|
| Baltimore | 1 | 2018 | 230 | 0.040 |
Why?
|
| Laser Therapy | 1 | 2004 | 1082 | 0.040 |
Why?
|
| Amikacin | 1 | 2017 | 48 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2024 | 1165 | 0.040 |
Why?
|
| Cefoxitin | 1 | 2017 | 35 | 0.040 |
Why?
|
| United States | 6 | 2021 | 71902 | 0.040 |
Why?
|
| Inflammation | 2 | 2021 | 10709 | 0.030 |
Why?
|
| Clarithromycin | 1 | 2017 | 85 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 12951 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 73708 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2021 | 1955 | 0.030 |
Why?
|
| Phylogeny | 1 | 2023 | 2774 | 0.030 |
Why?
|
| Emergency Service, Hospital | 2 | 2017 | 7798 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2109 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 780 | 0.030 |
Why?
|
| Cities | 1 | 2017 | 541 | 0.030 |
Why?
|
| Peru | 1 | 2017 | 884 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 64242 | 0.030 |
Why?
|
| Hematologic Tests | 1 | 2015 | 238 | 0.030 |
Why?
|
| Uganda | 1 | 2018 | 1324 | 0.030 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2014 | 79 | 0.030 |
Why?
|
| Serum | 1 | 2015 | 210 | 0.030 |
Why?
|
| Utilization Review | 1 | 2015 | 382 | 0.030 |
Why?
|
| Penicillins | 1 | 2016 | 406 | 0.030 |
Why?
|
| Hospital Charges | 1 | 2014 | 351 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1505 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2015 | 544 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1704 | 0.020 |
Why?
|
| Ileum | 1 | 2014 | 556 | 0.020 |
Why?
|
| Massachusetts | 1 | 2024 | 8815 | 0.020 |
Why?
|
| Gynecology | 1 | 2017 | 523 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 538 | 0.020 |
Why?
|
| Health Resources | 1 | 2017 | 931 | 0.020 |
Why?
|
| Bronchiolitis | 1 | 2017 | 481 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2021 | 4087 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 927 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2006 | 18936 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2378 | 0.020 |
Why?
|
| Obstetrics | 1 | 2017 | 664 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 824 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2014 | 1828 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 1004 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1668 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2014 | 529 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3664 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1632 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 29712 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3526 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2023 | 7927 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11709 | 0.020 |
Why?
|
| Heart | 1 | 2021 | 4382 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 1110 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2013 | 784 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5856 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 58755 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2009 | 745 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2017 | 2505 | 0.020 |
Why?
|
| Radiography | 1 | 2017 | 6956 | 0.020 |
Why?
|
| Taxoids | 1 | 2009 | 666 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3562 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2267 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12047 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2212 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8550 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 2219 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2017 | 3793 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2009 | 2211 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12601 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 20992 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2012 | 3005 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2009 | 2552 | 0.010 |
Why?
|
| Asthma | 1 | 2017 | 6172 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2015 | 54092 | 0.010 |
Why?
|
| Hospitalization | 1 | 2015 | 10634 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 36045 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 42045 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 167718 | 0.010 |
Why?
|
| HIV Infections | 1 | 2018 | 17270 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 39020 | 0.000 |
Why?
|